Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial ☆
Tóm tắt
Từ khóa
Tài liệu tham khảo
Arnold, 2004, , for the Duloxetine Fibromyalgia Trial Group. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder., Arthritis Rheum, 50, 2974, 10.1002/art.20485
Arnold, 2005, A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder., Pain, 119, 5, 10.1016/j.pain.2005.06.031
Basbaum, 1984, Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry., Annu Rev Neurosci, 7, 309, 10.1146/annurev.ne.07.030184.001521
Bech, 2006, Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder., Psychopharmacology, 188, 273, 10.1007/s00213-006-0505-1
Burckhardt, 1991, The fibromyalgia impact questionnaire: development and validation., J Rheumatol, 18, 728
Clark, 1993, The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception., Brain Res, 616, 200, 10.1016/0006-8993(93)90210-E
Clauw, 2003, Chronic widespread pain and fibromyalgia: what we know, and what we need to know., Best Pract Res Clin Rheumatol, 17, 685, 10.1016/S1521-6942(03)00035-4
Cleeland, 1994, Pain assessment: global use of the Brief Pain Inventory., Ann Acad Med Singapore, 23, 129
Crofford, 2005, , and the Pregabalin 1008-105 Study Group. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial., Arthritis Rheum, 52, 1264, 10.1002/art.20983
Detke, 2002, Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial., J Clin Psychiatry, 63, 308, 10.4088/JCP.v63n0407
Detke, 2002, Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression., J Psychiatr Res, 36, 383, 10.1016/S0022-3956(02)00060-2
Faries, 2000, The responsiveness of the Hamilton Depression Rating Scale., J Psychiatr Res, 34, 3, 10.1016/S0022-3956(99)00037-0
Fischer, 1986, Pressure threshold meter: its use for quantification of tender spots., Arch Phys Med Rehabil, 67, 836
Gahimer, 2007, A retrospective pooled analysis of duloxetine safety in 23,983 subjects., Curr Med Res Opin, 23, 175, 10.1185/030079906X162719
Gendreau, 2005, Efficacy of milnacipran in patients with fibromyalgia., J Rheumatol, 32, 1975
Goldstein, 2005, Duloxetine vs. placebo in patients with painful diabetic neuropathy., Pain, 116, 109, 10.1016/j.pain.2005.03.029
Greist, 2004, Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine., Clin Ther, 26, 1446, 10.1016/j.clinthera.2004.09.010
Hamilton, 1960, A rating scale for depression., J Neurol Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56
Hartford, 2007, Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial., Int Clin Psychopharmacol, 22, 167, 10.1097/YIC.0b013e32807fb1b2
Holman, 2005, A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications., Arthritis Rheum, 52, 2495, 10.1002/art.21191
Koponen, 2007, Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians., Prim Care Companion J Clin Psychiatry, 9, 100, 10.4088/PCC.v09n0203
Mease, 2005, Fibromyalgia syndrome., J Rheumatol, 32, 2270
Mease, 2007, Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment., J Rheumatol, 32, 6
Mease, 2007, Fibromyalgia syndrome., J Rheumatol, 34, 1415
Raskin, 2005, A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain., Pain Med, 6, 346, 10.1111/j.1526-4637.2005.00061.x
Russell, 1992, Cerebrospinal fluid biogenic amine metabolites in fibromyalgiafibrositis syndrome and rheumatoid arthritis., Arthritis Rheum, 35, 550, 10.1002/art.1780350509
Russell, 1992, Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgiafibrositis syndrome., J Rheumatol, 19, 104
Sheehan, 1998, The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10., J Clin Psychiatry, 59, 22
Smets, 1995, The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue., J Psychosom Res, 39, 315, 10.1016/0022-3999(94)00125-O
Vitton, 2004, A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia., Hum Psychopharmacol, 19, S27, 10.1002/hup.622
Wernicke, 2006, A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain., Neurology, 67, 1411, 10.1212/01.wnl.0000240225.04000.1a
Wernicke, 2007, An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies., Drug Saf, 30, 437, 10.2165/00002018-200730050-00007
Westfall, 2001, Optimally weighted, fixed sequence and gatekeeper multiple testing procedures., J Stat Plan Infer, 99, 25, 10.1016/S0378-3758(01)00077-5
White, 2001, Classification, epidemiology, and natural history of fibromyalgia., Curr Pain Headache Rep, 5, 320, 10.1007/s11916-001-0021-2
Wolfe, 1995, The prevalence and characteristics of fibromyalgia in the general population., Arthritis Rheum, 38, 19, 10.1002/art.1780380104
Wolfe, 1990, The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee., Arthritis Rheum, 33, 160, 10.1002/art.1780330203
Yunus, 1992, Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study., J Rheumatol, 19, 90